Recent studies in acute myeloid leukemia (AML) have revealed that epigenetic silencing of ATP1B1 through promoter‐region DNA methylation and histone modification leads to instability of the Na/K‐ATPase pump, highlighting this pathway as a potential therapeutic target [47]. The gene discussed is ATP1B1; the disease is acute myeloid leukemia.